Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shengping Wang

Showing results (131-140 of 150) with videos related to

Pageof 15
Sort By:
The Oncologist|January 4, 2021
A Phase II Study of Apatinib in Patients with Chemotherapy-Refractory Esophageal Squamous Cell Carcinoma (ESO-Shanghai 11)Li Chu, Yun Chen, Qi Liu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 20, 2019
Lung Adenocarcinomas Manifesting as Radiological Part-Solid Nodules Define a Special Clinical SubtypeTing Ye, Lin Deng, Shengping Wang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|March 2, 2016
Layered MoS2 Hollow Spheres for Highly-Efficient Photothermal Therapy of Rabbit Liver Orthotopic Transplantation TumorsLongfei Tan, Shengping Wang, Ke Xu, et al.
Journal of Thoracic Disease|October 18, 2021
Clinicopathologic features and prognostic value of epidermal growth factor receptor mutation in patients with pT1a and pT1b invasive lung adenocarcinoma after surgical resectionShiqi Chen, Siqian Yang, Yang Zhang, et al.
International Journal of Cancer|December 16, 2021
Overall survival benefit of osimertinib and clinical value of upfront cranial local therapy in untreated EGFR-mutant nonsmall cell lung cancer with brain metastasisYang Zhao, Shuyan Li, Xi Yang, et al.
Journal of Cancer Research and Clinical Oncology|May 2, 2020
Ground-glass opacity-featured lung adenocarcinoma has no response to chemotherapyYang Zhang, Chaoqiang Deng, Xiao Ma, et al.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2022
Prognostic implication of tumor spread through air spaces in patients with pathologic N0 lung adenocarcinomaShiqi Chen, Ting Ye, Siqian Yang, et al.
The Annals of Thoracic Surgery|April 11, 2021
Subsolid Lesions Exceeding 3 Centimeters: The Ground-Glass Opacity Component Still MattersFanfan Fan, Yang Zhang, Fangqiu Fu, et al.
JAMA Network Open|October 16, 2023
Radiologic Identification of Pathologic Tumor Invasion in Patients With Lung AdenocarcinomaTing Ye, Haoxuan Wu, Shengping Wang, et al.
Translational Oncology|May 19, 2017
Should Nonsmokers Be Excluded from Early Lung Cancer Screening with Low-Dose Spiral Computed Tomography? Community-Based Practice in ShanghaiXiaoyang Luo, Shanbo Zheng, Quan Liu, et al.
Pageof 15

Showing results (131-140 of 150) with videos related to

Sort By:
Pageof 15
The Oncologist|January 4, 2021
A Phase II Study of Apatinib in Patients with Chemotherapy-Refractory Esophageal Squamous Cell Carcinoma (ESO-Shanghai 11)Li Chu, Yun Chen, Qi Liu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 20, 2019
Lung Adenocarcinomas Manifesting as Radiological Part-Solid Nodules Define a Special Clinical SubtypeTing Ye, Lin Deng, Shengping Wang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|March 2, 2016
Layered MoS2 Hollow Spheres for Highly-Efficient Photothermal Therapy of Rabbit Liver Orthotopic Transplantation TumorsLongfei Tan, Shengping Wang, Ke Xu, et al.
Journal of Thoracic Disease|October 18, 2021
Clinicopathologic features and prognostic value of epidermal growth factor receptor mutation in patients with pT1a and pT1b invasive lung adenocarcinoma after surgical resectionShiqi Chen, Siqian Yang, Yang Zhang, et al.
International Journal of Cancer|December 16, 2021
Overall survival benefit of osimertinib and clinical value of upfront cranial local therapy in untreated EGFR-mutant nonsmall cell lung cancer with brain metastasisYang Zhao, Shuyan Li, Xi Yang, et al.
Journal of Cancer Research and Clinical Oncology|May 2, 2020
Ground-glass opacity-featured lung adenocarcinoma has no response to chemotherapyYang Zhang, Chaoqiang Deng, Xiao Ma, et al.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2022
Prognostic implication of tumor spread through air spaces in patients with pathologic N0 lung adenocarcinomaShiqi Chen, Ting Ye, Siqian Yang, et al.
The Annals of Thoracic Surgery|April 11, 2021
Subsolid Lesions Exceeding 3 Centimeters: The Ground-Glass Opacity Component Still MattersFanfan Fan, Yang Zhang, Fangqiu Fu, et al.
JAMA Network Open|October 16, 2023
Radiologic Identification of Pathologic Tumor Invasion in Patients With Lung AdenocarcinomaTing Ye, Haoxuan Wu, Shengping Wang, et al.
Translational Oncology|May 19, 2017
Should Nonsmokers Be Excluded from Early Lung Cancer Screening with Low-Dose Spiral Computed Tomography? Community-Based Practice in ShanghaiXiaoyang Luo, Shanbo Zheng, Quan Liu, et al.
Pageof 15